234 related articles for article (PubMed ID: 36855810)
21. miR-877-3p as a Potential Tumour Suppressor of Oesophageal Squamous Cell Carcinoma.
Fukuda T; Baba H; Okumura T; Kanda M; Akashi T; Tanaka H; Miwa T; Watanabe T; Hirano K; Sekine S; Hashimoto I; Shibuya K; Hojo S; Yoshioka I; Matsui K; Kodera Y; Fujii T
Anticancer Res; 2023 Jan; 43(1):35-43. PubMed ID: 36585184
[TBL] [Abstract][Full Text] [Related]
22. Single-cell RNA-seq of esophageal squamous cell carcinoma cell line with fractionated irradiation reveals radioresistant gene expression patterns.
Yang L; Zhang X; Hou Q; Huang M; Zhang H; Jiang Z; Yue J; Wu S
BMC Genomics; 2019 Jul; 20(1):611. PubMed ID: 31345182
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of cyclin-dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance.
Zhang HJ; Chen G; Chen SW; Fu ZW; Zhou HF; Feng ZB; Mo JX; Li CB; Liu J
FEBS Open Bio; 2021 Nov; 11(11):3126-3141. PubMed ID: 34586751
[TBL] [Abstract][Full Text] [Related]
24. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
25. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
26. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
27. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
28. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma.
Jia Y; Zhang B; Zhang C; Kwong DL; Chang Z; Li S; Wang Z; Han H; Li J; Zhong Y; Sui X; Fu L; Guan X; Qin Y
Adv Sci (Weinh); 2023 Mar; 10(7):e2204565. PubMed ID: 36709495
[TBL] [Abstract][Full Text] [Related]
29. Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma.
Qiu L; Yue J; Ding L; Yin Z; Zhang K; Zhang H
Cancer Lett; 2022 Oct; 546():215860. PubMed ID: 35948121
[TBL] [Abstract][Full Text] [Related]
30. Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma.
Wen J; Fang S; Hu Y; Xi M; Weng Z; Pan C; Luo K; Ling Y; Lai R; Xie X; Lin X; Lin T; Chen J; Liu Q; Fu J; Yang H
EBioMedicine; 2022 Dec; 86():104371. PubMed ID: 36434949
[TBL] [Abstract][Full Text] [Related]
31. High-mobility group AT-hook 2 promotes growth and metastasis and is regulated by miR-204-5p in oesophageal squamous cell carcinoma.
Zhang H; Wu X; Sui Z; Ma Z; Gong L; Meng B; Tang P; Yu Z
Eur J Clin Invest; 2021 Aug; 51(8):e13563. PubMed ID: 33901298
[TBL] [Abstract][Full Text] [Related]
32. The landscape and biological relevance of aberrant alternative splicing events in esophageal squamous cell carcinoma.
Wu Q; Zhang Y; An H; Sun W; Wang R; Liu M; Zhang K
Oncogene; 2021 Jun; 40(24):4184-4197. PubMed ID: 34079089
[TBL] [Abstract][Full Text] [Related]
33. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
Zheng Y; Chen Z; Han Y; Han L; Zou X; Zhou B; Hu R; Hao J; Bai S; Xiao H; Li WV; Bueker A; Ma Y; Xie G; Yang J; Chen S; Li H; Cao J; Shen L
Nat Commun; 2020 Dec; 11(1):6268. PubMed ID: 33293583
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
Ha SY; Yeo SY; Xuan YH; Kim SH
PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
[TBL] [Abstract][Full Text] [Related]
35. Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma.
Huang H; Li N; Liang Y; Li R; Tong X; Xiao J; Tang H; Jiang D; Xie K; Fang C; Chen S; Li G; Wang B; Wang J; Luo H; Guo L; Ma H; Jiang W; Feng Y
Clin Transl Med; 2023 Nov; 13(11):e1493. PubMed ID: 38009315
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.
Gopalan V; Islam F; Pillai S; Tang JC; Tong DK; Law S; Chan KW; Lam AK
Exp Cell Res; 2016 Nov; 348(2):146-154. PubMed ID: 27658568
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
Yao Y; Xuan H; Wang J; Gong L; Gao W
Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
[TBL] [Abstract][Full Text] [Related]
38. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma.
Wu J; Gao FX; Wang C; Qin M; Han F; Xu T; Hu Z; Long Y; He XM; Deng X; Ren DL; Dai TY
J Exp Clin Cancer Res; 2019 Jul; 38(1):321. PubMed ID: 31324197
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-155 acts as a diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
Zheng YJ; Liang TS; Wang J; Zhao JY; Zhai SN; Yang DK; Wang LD
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):977-982. PubMed ID: 32573268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
